Monotherapy efficacy of blood–brain barrier permeable small molecule reactivators of protein phosphatase 2A in glioblastoma

Glioblastoma is a fatal disease in which most targeted therapies have clinically failed. However, pharmacological reactivation of tumour suppressors has not been thoroughly studied as yet as a glioblastoma therapeutic strategy. Tumour suppressor protein phosphatase 2A is inhibited by non-genetic mec...

Descripción completa

Detalles Bibliográficos
Autores principales: Merisaari, Joni, Denisova, Oxana V, Doroszko, Milena, Le Joncour, Vadim, Johansson, Patrik, Leenders, William P J, Kastrinsky, David B, Zaware, Nilesh, Narla, Goutham, Laakkonen, Pirjo, Nelander, Sven, Ohlmeyer, Michael, Westermarck, Jukka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425423/
https://www.ncbi.nlm.nih.gov/pubmed/32954276
http://dx.doi.org/10.1093/braincomms/fcaa002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425423/
https://www.ncbi.nlm.nih.gov/pubmed/32954276
http://dx.doi.org/10.1093/braincomms/fcaa002

Ejemplares similares